Skip to content
The Standard of American Enterprise

Tang Capital Management

The Carnegie Standard reported on Tang Capital Management on October 7, 2026.

What we have reported

  1. October 7, 2026

    Tang Capital files for $75 million SPAC IPO priced at $25 a share

    Sponsor Tang Capital Management has given a non-binding indication that it would buy $50 million of stock at the offering price, roughly 67% of the deal, and said it plans to take more than half of the shares even if outside demand is strong. Kevin Tang, founder and president of Tang Capital Management and chief executive of Aurinia Pharmaceuticals, is chief executive and chair.